Isolation and characterization of cidofovir resistant vaccinia viruses
The emergence of drug resistant viruses, together with the possibility of increased virulence, is an important concern in the development of new antiviral compounds. Cidofovir (CDV) is a phosphonate nucleotide that is approved for use against cytomegalovirus retinitis and for the emergency treatment of smallpox or complications following vaccination.
One mode of action for CDV has been demonstrated to be the inhibition of the viral DNA polymerase.
Results: We have isolated several CDV resistant (CDVR) vaccinia viruses through a one step process, two of which have unique single mutations within the DNA polymerase.
An additional resistant virus isolate provides evidence of a second site mutation within the genome involved in CDV resistance. The CDVR viruses were 3-7 fold more resistant to the drug than the parental viruses.
The virulence of the CDVR viruses was tested in mice inoculated intranasally and all were found to be attenuated.
Conclusions: Resistance to CDV in vaccinia virus can be conferred individually by at least two different mutations within the DNA polymerase gene.
Additional genes may be involved. This one step approach for isolating resistant viruses without serial passage and in the presence of low doses of drug minimizes unintended secondary mutations and is applicable to other potential antiviral agents.
Author: Marie N Becker, Maria Obraztsova, Earl R Kern, Debra C Quenelle, Kathy A Keith, Mark N Prichard, Ming Luo and Richard W Moyer
Credits/Source: Virology Journal 2008, 5:58
Published on: 2008-05-14
Copyright by the authors listed above - made available via BioMedCentral (Open Access). Please
make sure to read our disclaimer prior to contacting 7thSpace Interactive. To contact our editors, visit our online helpdesk. If you wish submit your own press release, click here.
Social Bookmarking
RETWEET This! | Digg this! | Post to del.icio.us | Post to Furl | Add to Netscape | Add to Yahoo! | Rojo
|
|
